SCHEMBL8123793

SCHEMBL8123793

COCOc1ccc(C(=O)O)cc1.COCOc1ccc(C(=O)O)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.61
CA2 P00918 1/20 0.61
NPC1 O15118 1/20 0.59
POLB P06746 1/20 0.59
RAB9A P51151 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
PKM P14618 1/20 0.58
PLA2G4B P0C869 3/20 0.56
MAPK1 P28482 2/20 0.56
TSHR P16473 2/20 0.56
TP53 P04637 1/20 0.56
NR4A1 P22736 1/20 0.55
NR4A2 P43354 1/20 0.55
NR4A3 Q92570 1/20 0.55
RXRA P19793 1/20 0.54
RXRB P28702 1/20 0.54
USP2 O75604 1/20 0.53
ALOX15 P16050 1/20 0.53
HSD17B10 Q99714 1/20 0.53
RARB P10826 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL155030 1.00 CA1 (0.61) CA1CA2NPC1POLBRAB9A
SCHEMBL18319953 0.94 CA1 (0.55) CA1CA2NPC1POLBRAB9A
SCHEMBL450829 0.87 PKM (0.67) CA1CA2NPC1POLBRAB9A
SCHEMBL3798190 0.86 CES2 (0.59) NPC1POLBRAB9ASMN1; SMN2
SCHEMBL9549256 0.86 KMT2A (0.53) RAB9ASMN1; SMN2MAPK1HTT
SCHEMBL1503531 0.85 PKM (0.56) CA1CA2NPC1POLBRAB9A
SCHEMBL657699 0.84 L3MBTL1 (0.66) POLBRAB9ASMN1; SMN2HTT
SCHEMBL5390728 0.84 KDM4E (0.67) CA1CA2TSHRTP53HSD17B10
SCHEMBL7661858 0.83 GAA (0.62) NPC1RAB9ASMN1; SMN2MAPK1HTT
SCHEMBL2778728 0.82 MAPT (0.47) NPC1POLBRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0663393-B1 3-Amino/hydroxy-4- 4-benzoylphenylcarboxylamino/oxy -azepanes and their homologies as protein kinase inhibitors HOFFMANN LA ROCHE (CH) 2000-07-05 EP disclosed
US-5914406-A ENZYME INHIBITOR; USEFUL FOR TREATMENT OF INFLAMMATORY SKIN DISORDERS AND ALOPECIA HOFFMAN-LA ROCHE INC. (US) 1999-06-22 US disclosed
US-5750706-A TREATMENT OF INFLAMMATORY SKIN DISORDERS AND ALOPECIA HOFFMANN-LA ROCHE INC. (US) 1998-05-12 US disclosed
US-5583222-A ANTIINFLAMMATORY AGENTS FOR TREATMENT OF SKIN DISORDERS HOFFMANN-LA ROCHE INC. (US) 1996-12-10 US disclosed
EP-0663393-A1 Novel 3-amino/hydroxy-4- 4-benzoylphenylcarboxylamino/oxy -azepanes and their homologies as protein kinase inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1995-07-19 EP disclosed